Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Cisplatin and Lentinan

supplement:

Lentinan

Research Papers that Mention the Interaction

Conclusions: The current evidence prompted that Lentinan combined with cisplatin in thoracic injection might benefit patients with NSCLC on a certain extent; this systematic review revealed some definite conclusions about the application of Lentinan combined with cisplatin in thoracic injection for NSCLC.
Medicine  •  2021  |  View Paper
BACKGROUND Many studies have investigated the efficacy and safety of lentinan combined with cisplatin versus cisplatin alone for controlling malignant pleural effusion (MPE).
In addition, lentinan combined with cisplatin showed a better benefit of quality of life (QOL) compared with cisplatin alone (P < 0.001).
RESULTS The overall response rate (ORR) of le tinan co mbined with cis platin fo r controlling MPE was significantly higher than that of cisplatin alone (P < 0.001).
The American journal of the medical sciences  •  2019  |  View Paper
Lentinan has the ability of inducing BGC823 cell apoptosis and this effect is enhanced when combined with docetaxel and cisplatin.
Tumor Biology  •  2013  |  View Paper
These results indicated that lentinan administration decreases tissue GST‐II and GST‐III contents and enhances the sensitivity of colon 26 tumor to CDDP.
Japanese journal of cancer research : Gann  •  1996  |  View Paper
In addition, lentinan and cisplatin co-treatment induced mitochondrial depolarization.
This suggested that lentinan combinatorial therapy with cisplatin engaged a different signalling pathway to kill the liver cancer cells and that adjuvant therapy with lentinan can reduce the dose of cisplatin and thus reduce the possibility of chemo-resistance.
We also showed that lentinan hugely reduced the dose of cisplatin to induce certain amount of death and that lentinan co-treatment with cisplatin enhanced the Apaf1 transcription in HepG2 cells while lentinan or cisplatin alone failed to alter the transcription.
Biochemical and biophysical research communications  •  2021  |  View Paper
Lentinan … cisplatin significantly improved complete response [Risk ratio (RR) = 1.68, 95% confidence intervals (CI) (1.51 to 1.87), p < 0.00001, Fig.3a] and … (1.41 to 1.62), p < 0.00001, Fig.4], and decreased the risk of treatment failure, myelosuppression, gastrointestinal reaction, and chest pain.
Phytomedicine : international journal of phytotherapy and phytopharmacology  •  2020  |  View Paper